Cargando…
Topical treatment with fresh human milk versus emollient on atopic eczema spots in young children: a small, randomized, split body, controlled, blinded pilot study
BACKGROUND: Public health nurses report on effects of fresh human milk as treatment for conjunctivitis, rhinitis and atopic eczema (AE), the latter being highly prevalent in early childhood. Emollients and topical corticosteroids are first line treatment of AE. As many caregivers have steroid phobia...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4424556/ https://www.ncbi.nlm.nih.gov/pubmed/25935520 http://dx.doi.org/10.1186/s12895-015-0027-9 |
_version_ | 1782370349390757888 |
---|---|
author | Berents, Teresa Løvold Rønnevig, Jørgen Søyland, Elisabeth Gaustad, Peter Nylander, Gro Løland, Beate Fossum |
author_facet | Berents, Teresa Løvold Rønnevig, Jørgen Søyland, Elisabeth Gaustad, Peter Nylander, Gro Løland, Beate Fossum |
author_sort | Berents, Teresa Løvold |
collection | PubMed |
description | BACKGROUND: Public health nurses report on effects of fresh human milk as treatment for conjunctivitis, rhinitis and atopic eczema (AE), the latter being highly prevalent in early childhood. Emollients and topical corticosteroids are first line treatment of AE. As many caregivers have steroid phobia, alternative treatment options for mild AE are of interest. The aim of this small pilot study was to assess the potential effects and risks of applying fresh human milk locally on eczema spots in children with AE. METHODS: This was a split body, controlled, randomized and physician blinded pilot study, of children with AE with two similar contralateral eczema spots having a mother breastfeeding the child or a sibling. Fresh expressed milk and emollient was applied on the intervention spot and emollient alone on the control area, three times a day for four weeks. The severity and area of the eczema spots was evaluated weekly, and samples from milk and the spots were analysed weekly with respect to bacterial colonisation. RESULTS: Of nine patients included, six completed the study. Mean age at inclusion was 18.5 months. The spots examined were localized on the arms, legs or cheeks. The spots were similar in severity, but differed in area. In one patient the eczema ceased after inclusion. In four patients both control and intervention areas increased during the intervention. The relative change in eczema area compared to baseline showed less increase in the intervention spots in two patients, whereas the opposite was observed in three. In four children Staphylococcus aureus was found in their eczema once or more. In three of the 28 human milk samples, Staphylococcus aureus, alfa haemolytic streptococci or coagulase negative staphylococci were detected. Staphylococcus aureus was found once both in human milk and in the eczema spots, no clinical signs of infection were however observed. No secondary infection due to milk application was detected. CONCLUSION: In this small pilot study, no effect was found on eczema spots treated with topical application of fresh human milk. (ClinicalTrials.gov Identifier, NCT02381028). |
format | Online Article Text |
id | pubmed-4424556 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-44245562015-05-09 Topical treatment with fresh human milk versus emollient on atopic eczema spots in young children: a small, randomized, split body, controlled, blinded pilot study Berents, Teresa Løvold Rønnevig, Jørgen Søyland, Elisabeth Gaustad, Peter Nylander, Gro Løland, Beate Fossum BMC Dermatol Research Article BACKGROUND: Public health nurses report on effects of fresh human milk as treatment for conjunctivitis, rhinitis and atopic eczema (AE), the latter being highly prevalent in early childhood. Emollients and topical corticosteroids are first line treatment of AE. As many caregivers have steroid phobia, alternative treatment options for mild AE are of interest. The aim of this small pilot study was to assess the potential effects and risks of applying fresh human milk locally on eczema spots in children with AE. METHODS: This was a split body, controlled, randomized and physician blinded pilot study, of children with AE with two similar contralateral eczema spots having a mother breastfeeding the child or a sibling. Fresh expressed milk and emollient was applied on the intervention spot and emollient alone on the control area, three times a day for four weeks. The severity and area of the eczema spots was evaluated weekly, and samples from milk and the spots were analysed weekly with respect to bacterial colonisation. RESULTS: Of nine patients included, six completed the study. Mean age at inclusion was 18.5 months. The spots examined were localized on the arms, legs or cheeks. The spots were similar in severity, but differed in area. In one patient the eczema ceased after inclusion. In four patients both control and intervention areas increased during the intervention. The relative change in eczema area compared to baseline showed less increase in the intervention spots in two patients, whereas the opposite was observed in three. In four children Staphylococcus aureus was found in their eczema once or more. In three of the 28 human milk samples, Staphylococcus aureus, alfa haemolytic streptococci or coagulase negative staphylococci were detected. Staphylococcus aureus was found once both in human milk and in the eczema spots, no clinical signs of infection were however observed. No secondary infection due to milk application was detected. CONCLUSION: In this small pilot study, no effect was found on eczema spots treated with topical application of fresh human milk. (ClinicalTrials.gov Identifier, NCT02381028). BioMed Central 2015-05-04 /pmc/articles/PMC4424556/ /pubmed/25935520 http://dx.doi.org/10.1186/s12895-015-0027-9 Text en © Berents et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Berents, Teresa Løvold Rønnevig, Jørgen Søyland, Elisabeth Gaustad, Peter Nylander, Gro Løland, Beate Fossum Topical treatment with fresh human milk versus emollient on atopic eczema spots in young children: a small, randomized, split body, controlled, blinded pilot study |
title | Topical treatment with fresh human milk versus emollient on atopic eczema spots in young children: a small, randomized, split body, controlled, blinded pilot study |
title_full | Topical treatment with fresh human milk versus emollient on atopic eczema spots in young children: a small, randomized, split body, controlled, blinded pilot study |
title_fullStr | Topical treatment with fresh human milk versus emollient on atopic eczema spots in young children: a small, randomized, split body, controlled, blinded pilot study |
title_full_unstemmed | Topical treatment with fresh human milk versus emollient on atopic eczema spots in young children: a small, randomized, split body, controlled, blinded pilot study |
title_short | Topical treatment with fresh human milk versus emollient on atopic eczema spots in young children: a small, randomized, split body, controlled, blinded pilot study |
title_sort | topical treatment with fresh human milk versus emollient on atopic eczema spots in young children: a small, randomized, split body, controlled, blinded pilot study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4424556/ https://www.ncbi.nlm.nih.gov/pubmed/25935520 http://dx.doi.org/10.1186/s12895-015-0027-9 |
work_keys_str_mv | AT berentsteresaløvold topicaltreatmentwithfreshhumanmilkversusemollientonatopiceczemaspotsinyoungchildrenasmallrandomizedsplitbodycontrolledblindedpilotstudy AT rønnevigjørgen topicaltreatmentwithfreshhumanmilkversusemollientonatopiceczemaspotsinyoungchildrenasmallrandomizedsplitbodycontrolledblindedpilotstudy AT søylandelisabeth topicaltreatmentwithfreshhumanmilkversusemollientonatopiceczemaspotsinyoungchildrenasmallrandomizedsplitbodycontrolledblindedpilotstudy AT gaustadpeter topicaltreatmentwithfreshhumanmilkversusemollientonatopiceczemaspotsinyoungchildrenasmallrandomizedsplitbodycontrolledblindedpilotstudy AT nylandergro topicaltreatmentwithfreshhumanmilkversusemollientonatopiceczemaspotsinyoungchildrenasmallrandomizedsplitbodycontrolledblindedpilotstudy AT lølandbeatefossum topicaltreatmentwithfreshhumanmilkversusemollientonatopiceczemaspotsinyoungchildrenasmallrandomizedsplitbodycontrolledblindedpilotstudy |